Skip to main content
. 2003 Apr;41(4):1440–1446. doi: 10.1128/JCM.41.4.1440-1446.2003

TABLE 3.

In vitro susceptibilities of Candida spp. to voriconazole determined by BMD and Etest methods, ARTEMIS Program, 2001

Species (no. of isolates tested) Test method Cumulative % susceptible at MIC (μg/ml) ofa:
0.007 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8
C. albicans (916) BMD 79 94 99 99 99 99 99 99 99 100
Etest 73 98 99 99 99 99 99 99 99 100
C. glabrata (235) BMD 0 0 1 6 29 74 88 93 97 99 100
Etest 0 1 3 12 30 66 86 92 95 96 97
C. parapsilosis (198) BMD 18 63 83 96 99 99 100
Etest 25 64 85 97 99 99 100
C. tropicalis (150) BMD 4 11 41 87 98 100
Etest 3 22 71 92 99 100
C. krusei (43) BMD 0 0 0 0 16 65 93 100
Etest 0 0 0 0 7 72 95 100
C. lusitaniae (24) BMD 79 88 88 96 96 96 100
Etest 54 92 92 96 96 96 100
a

MICs were determined according to NCCLS guidelines (19).